CellSource Co Ltd
TSE:4880

Watchlist Manager
CellSource Co Ltd Logo
CellSource Co Ltd
TSE:4880
Watchlist
Price: 1 096 JPY -3.69%
Market Cap: 21.7B JPY
Have any thoughts about
CellSource Co Ltd?
Write Note

CellSource Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellSource Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
CellSource Co Ltd
TSE:4880
Pre-Tax Income
ÂĄ1.2B
CAGR 3-Years
44%
CAGR 5-Years
33%
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Pre-Tax Income
ÂĄ9B
CAGR 3-Years
66%
CAGR 5-Years
19%
CAGR 10-Years
10%
C
Chiome Bioscience Inc
TSE:4583
Pre-Tax Income
-ÂĄ1.2B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Precision System Science Co Ltd
TSE:7707
Pre-Tax Income
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medinet Co Ltd
TSE:2370
Pre-Tax Income
-ÂĄ1.3B
CAGR 3-Years
-21%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
WDB coco Co Ltd
TSE:7079
Pre-Tax Income
ÂĄ1.3B
CAGR 3-Years
34%
CAGR 5-Years
30%
CAGR 10-Years
N/A
No Stocks Found

CellSource Co Ltd
Glance View

Market Cap
21.7B JPY
Industry
Life Sciences Tools & Services

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 90 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Intrinsic Value
969.93 JPY
Overvaluation 12%
Intrinsic Value
Price

See Also

What is CellSource Co Ltd's Pre-Tax Income?
Pre-Tax Income
1.2B JPY

Based on the financial report for Oct 31, 2023, CellSource Co Ltd's Pre-Tax Income amounts to 1.2B JPY.

What is CellSource Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
33%

Over the last year, the Pre-Tax Income growth was -22%. The average annual Pre-Tax Income growth rates for CellSource Co Ltd have been 44% over the past three years , 33% over the past five years .

Back to Top